Oncology medications;TARGETED ANTINEOPLASTIC MEDICATIONS BCR-ABL TYROSINE KINASE INHIBITORS: IMATINIB (PO)
0.0(0)
Studied by 0 people0.0(0)
Call Kai
Learn
Practice Test
Spaced Repetition
Match
Flashcards
Knowt PlayCard Sorting
1/5
There's no tags or description
Looks like no tags are added yet.
Study Analytics
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
6 Terms
1
New cards
mechanism of action for IMATINIB
Stops cancer growth by inhibiting intracellular enzymes - It binds to and blocks the activity of BCR-ABL
2
New cards
therapeutic use
Chronic myeloid leukemia
3
New cards
complications
GI discomfort
Flu-like symptoms
Edema
Hypokalemia
Neutropenia
4
New cards
contraindications
Clients with hypersensitivity
Liver disease
5
New cards
drug to drug interactions
Acetaminophen
Warfarin
Clarithromycin, erythromycin, ketoconazole
Carbamazepine, phenytoin
6
New cards
Nursing Education:
Take with food
Bleeding precautions
Monitor for infusion reaction & premedicate if prescribed
Protect from sun & assess for rash
Notify HCP of SOB
Report adverse reactions
Note 
Flashcards (167)